(Q50621370)

16 March 2018

title

Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma. (English)

1 reference

16 March 2018

Najah Nassif

7

1 reference

ORCID Public Data File 2021

author name string

James Favaloro

1

1 reference

16 March 2018

Tulita Liyadipitiya

2

1 reference

16 March 2018

Ross Brown

3

1 reference

16 March 2018

Shihong Yang

4

1 reference

16 March 2018

Hayley Suen

5

1 reference

16 March 2018

Narelle Woodland

6

1 reference

16 March 2018

Derek Hart

8

1 reference

16 March 2018

Phillip Fromm

9

1 reference

16 March 2018

Claire Weatherburn

10

1 reference

16 March 2018

John Gibson

11

1 reference

16 March 2018

P Joy Ho

12

1 reference

16 March 2018

Douglas Joshua

13

1 reference

16 March 2018

publication date

12 May 2014

1 reference

16 March 2018

published in

Leukemia & Lymphoma

1 reference

16 March 2018

volume

55

1 reference

16 March 2018

issue

12

1 reference

16 March 2018

page(s)

2893-2900

1 reference

16 March 2018

Myeloid-derived suppressor cells as regulators of the immune system

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Biology and clinical observations of regulatory T cells in cancer immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

The role of regulatory T cells and TH17 cells in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL5.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

How I treat patients who mobilize hematopoietic stem cells poorly

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Multidrug reverting activity toward leukemia cells in a group of new verapamil analogues with low cardiovascular activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.904511

10.3109/10428194.2014.904511

21 January 2018

Identifiers

DOI

1 reference

16 March 2018

PubMed ID

24625328

1 reference

16 March 2018